LIG1 and urinary bladder cancer: In the drug treatment prediction analysis, the GDSC1 database analysis was used to show that bladder cancer with high LIG1 expression exhibited resistance to a series of drugs including AZD1332, PARP9495, Dyrk1b0191, AZD5438, Bleomycin1392, Bleomycin1378, Refametinib1526, Selumetinib1498 and others.